FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38845849> ?p ?o ?g. }

• Q38845849 description "2016 nî lūn-bûn" @default.
• Q38845849 description "2016年の論文" @default.
• Q38845849 description "2016年論文" @default.
• Q38845849 description "2016年論文" @default.
• Q38845849 description "2016年論文" @default.
• Q38845849 description "2016年論文" @default.
• Q38845849 description "2016年論文" @default.
• Q38845849 description "2016年论文" @default.
• Q38845849 description "2016年论文" @default.
• Q38845849 description "2016年论文" @default.
• Q38845849 description "2016年论文" @default.
• Q38845849 description "2016年论文" @default.
• Q38845849 description "2016年论文" @default.
• Q38845849 description "2016년 논문" @default.
• Q38845849 description "article científic" @default.
• Q38845849 description "article scientific" @default.
• Q38845849 description "article scientifique" @default.
• Q38845849 description "articol științific" @default.
• Q38845849 description "articolo scientifico" @default.
• Q38845849 description "artigo científico" @default.
• Q38845849 description "artigo científico" @default.
• Q38845849 description "artigo científico" @default.
• Q38845849 description "artikel ilmiah" @default.
• Q38845849 description "artikull shkencor" @default.
• Q38845849 description "artikulong pang-agham" @default.
• Q38845849 description "artykuł naukowy" @default.
• Q38845849 description "artículo científico publicado en 2016" @default.
• Q38845849 description "artículu científicu espublizáu en 2016" @default.
• Q38845849 description "bilimsel makale" @default.
• Q38845849 description "bài báo khoa học" @default.
• Q38845849 description "naučni članak" @default.
• Q38845849 description "scienca artikolo" @default.
• Q38845849 description "scientific article published on June 2016" @default.
• Q38845849 description "scientific article published on June 2016" @default.
• Q38845849 description "scientific article published on June 2016" @default.
• Q38845849 description "teaduslik artikkel" @default.
• Q38845849 description "tieteellinen artikkeli" @default.
• Q38845849 description "tudományos cikk" @default.
• Q38845849 description "vedecký článok" @default.
• Q38845849 description "vetenskaplig artikel" @default.
• Q38845849 description "videnskabelig artikel" @default.
• Q38845849 description "vitenskapelig artikkel" @default.
• Q38845849 description "vitskapeleg artikkel" @default.
• Q38845849 description "vědecký článek" @default.
• Q38845849 description "wetenschappelijk artikel" @default.
• Q38845849 description "wissenschaftlicher Artikel" @default.
• Q38845849 description "επιστημονικό άρθρο" @default.
• Q38845849 description "мақолаи илмӣ" @default.
• Q38845849 description "наукова стаття, опублікована в червні 2016" @default.
• Q38845849 description "научна статия" @default.
• Q38845849 description "научная статья" @default.
• Q38845849 description "научни чланак" @default.
• Q38845849 description "научни чланак" @default.
• Q38845849 description "מאמר מדעי" @default.
• Q38845849 description "مقالة علمية نشرت في يونيو 2016" @default.
• Q38845849 description "জুন ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q38845849 description "บทความทางวิทยาศาสตร์" @default.
• Q38845849 description "სამეცნიერო სტატია" @default.
• Q38845849 name "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 name "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 name "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 type Item @default.
• Q38845849 label "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 label "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 label "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 prefLabel "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 prefLabel "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 prefLabel "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 P1433 Q38845849-83152C71-66C3-4282-86F3-6EA183E70AF4 @default.
• Q38845849 P1476 Q38845849-02471D6B-E723-4B4A-83B8-9D6171DC7633 @default.
• Q38845849 P2093 Q38845849-02DF329C-EF0F-48A0-8DC3-B52AB11BAB18 @default.
• Q38845849 P2093 Q38845849-228C8BB5-D92B-42C2-AF07-2595C6F85246 @default.
• Q38845849 P2093 Q38845849-399AD3D4-24E0-47CD-819C-2F24DC8DABE8 @default.
• Q38845849 P2093 Q38845849-4AD9036B-67EC-4725-87A8-4D4696C22413 @default.
• Q38845849 P2093 Q38845849-9BC36CD1-05B5-4FDD-876A-788634E34A89 @default.
• Q38845849 P2093 Q38845849-D1195CE9-E7A5-40E9-A7A3-28A56EB010F2 @default.
• Q38845849 P2093 Q38845849-DAEB3928-EE98-47DB-B27D-6B21EF566DB1 @default.
• Q38845849 P304 Q38845849-16AECE4E-CC4C-4CFD-B8FF-EFA67F190866 @default.
• Q38845849 P31 Q38845849-46F34F3D-61A0-42A5-9472-BB6E465F674D @default.
• Q38845849 P356 Q38845849-32F08558-2D23-437C-931A-42A820BE67A4 @default.
• Q38845849 P433 Q38845849-9262F32D-FF1D-4A4C-9150-66A693DA1578 @default.
• Q38845849 P478 Q38845849-49CBEC1D-9C72-44C9-A423-453CBC2E0E2B @default.
• Q38845849 P50 Q38845849-89D2AA1E-DC12-47DF-B1B1-450EB30D616B @default.
• Q38845849 P577 Q38845849-921EC55C-57FC-492B-B102-488BB9893634 @default.
• Q38845849 P698 Q38845849-C38A8ECC-770C-47D1-8A0F-0D21CC85827D @default.
• Q38845849 P921 Q38845849-3E6FF3C9-F20C-4DC6-8E99-7AD0DE637B13 @default.
• Q38845849 P356 JMCP.2016.22.6.752 @default.
• Q38845849 P698 27231802 @default.
• Q38845849 P1433 Q23894211 @default.
• Q38845849 P1476 "Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis" @default.
• Q38845849 P2093 "Elizabeth Wu" @default.
• Q38845849 P2093 "Ivar S Jensen" @default.
• Q38845849 P2093 "Katherine A Sulham" @default.
• Q38845849 P2093 "Philip L Cyr" @default.
• Q38845849 P2093 "Scott Dufour" @default.
• Q38845849 P2093 "Thomas P Lodise" @default.
• Q38845849 P2093 "Weihong Fan" @default.
• Q38845849 P304 "752-764" @default.
• Q38845849 P31 Q13442814 @default.
• Q38845849 P356 "10.18553/JMCP.2016.22.6.752" @default.

• next